NYSE:CVSHealthcare
CVS Health Reshapes Portfolio With Omnicare Exit Drones And Biosimilars Focus
CVS Health (NYSE:CVS) is divesting its Omnicare subsidiary to GenieRx, with the transaction approved by the U.S. Bankruptcy Court and awaiting regulatory approvals.
The company is launching CVS Air Response, a drone-enabled healthcare logistics network with SkyfireAI and Thales Aerospace, focused on emergency and specialty pharmaceutical delivery.
CVS Caremark plans to update its commercial formularies on July 1, 2026, prioritizing FDA-approved biosimilars for key treatments to support...